Status:
UNKNOWN
Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's Disease
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to evaluate if patients' personality could be considerate as predictive factor of quality of life after the establishment of continuous infusion of dopaminergic treatments to o...
Detailed Description
Parkinson's disease leads to quality of life degradation, especially at level of motor complications. Second line treatment can be proposed to patients. There are deep brain stimulation and two treatm...
Eligibility Criteria
Inclusion
- Patients having Parkinson's disease according to United Kingdom Parkinson's Disease Society Brain Bank (UKPDSBB) criteria
- All Parkinson's patients presenting motor fluctuations and/or disabling dyskinesia and in need of the establishment of a second line treatment by subcutaneous apomorphine infusion or intrajejunal infusion of levodopa-carbidopa in the context of classical care of their Parkinson's disease
- Patient able to give its free and informed consent
- Patient having a social security
Exclusion
- Patients presenting atypical Parkinson's syndrome
- Patients having a deep brain stimulation
- Patient having a psychiatric disease such as: mood disorders, psychotic disorder…
- Patients presenting a cognitive decline evaluated by a Montreal Cognitive Assessment (MoCA) score inferior to 24
- None ability to give its consent
- Patients unable to realize the tests provided in the context of this study
- Patients under supervision, curators, or legal guardian
- Patients non-affiliated to a social security
- Patients in exclusion period of another study.
Key Trial Info
Start Date :
December 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 18 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03793491
Start Date
December 18 2018
End Date
June 18 2021
Last Update
January 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHToulouse
Toulouse, France, 31000